Search results with tag "In patients with renal"

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

www.ema.europa.eu

4 Renal impairment Modification of the buprenorphine/naloxone dose is not required in patients with renal impairment. Caution is recommended when dosing patients with severe renal …

Product, Patients, With, Summary, Learn, Summary of product, In patients with renal

Similar queries

SUMMARY OF PRODUCT, Renal, In patients with renal, Patients